Simplex Trading
FLNA

Simplex Trading’s Filana Therapeutics FLNA Stock Holding History

Simplex Trading’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.1K Sell
42,900
-19,500
-31% -$27.8K ﹤0.01% 6283
2026
Q1 		$105K Sell
62,400
-40,100
-39% -$82.6K ﹤0.01% 5022
2025
Q4 		$196K Sell
102,500
-39,300
-28% -$126K ﹤0.01% 4255
2025
Q3 		$412K Sell
141,800
-42,200
-23% -$97K ﹤0.01% 4074
2025
Q2 		$333K Sell
184,000
-36,100
-16% -$64.2K ﹤0.01% 3944
2025
Q1 		$330K Sell
220,100
-94,100
-30% -$237K ﹤0.01% 3841
2024
Q4 		$741K Buy
314,200
+147,900
+89% +$2.6M ﹤0.01% 3150
2024
Q3 		$4.89M Buy
166,300
+68,100
+69% +$1.57M ﹤0.01% 1501
2024
Q2 		$1.21M Buy
98,200
+6,700
+7% +$141K ﹤0.01% 2724
2024
Q1 		$1.26M Sell
91,500
-70,700
-44% -$1.63M ﹤0.01% 2872
2023
Q4 		$365K Sell
162,200
-78,000
-32% -$1.65M ﹤0.01% 4024
2023
Q3 		$4M Buy
240,200
+165,900
+223% +$3.29M ﹤0.01% 1500
2023
Q2 		$1.82M Sell
74,300
-122,700
-62% -$2.96M ﹤0.01% 2037
2023
Q1 		$4.75M Sell
197,000
-308,700
-61% -$8.55M ﹤0.01% 1332
2022
Q4 		$14.9M Buy
505,700
+11,400
+2% +$410K 0.02% 678
2022
Q3 		$20.7M Buy
494,300
+410,700
+491% +$11.1M 0.02% 501
2022
Q2 		$2.35M Sell
83,600
-25,500
-23% -$644K ﹤0.01% 1709
2022
Q1 		$4.05M Sell
109,100
-88,600
-45% -$3.75M ﹤0.01% 1426
2021
Q4 		$8.64M Buy
197,700
+91,900
+87% +$4.82M 0.01% 867
2021
Q3 		$9.39M Sell
105,800
-3,900
-4% -$325K 0.01% 757
2021
Q2 		$9.37M Buy
109,700
+109,060
+17,041% +$5.84M 0.01% 749
2021
Q1 		$2.88M Buy
+640
New +$25.2K 0.01% 1255
2020
Q3 		– Sell
-693
Closed -$213K – 8414
2020
Q2 		$213K Buy
693
+517
+294% +$2.35K ﹤0.01% 3925
2020
Q1 		$72K Buy
+176
New +$1.17K ﹤0.01% 4738

Other funds holding FLNA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Simplex Trading's FLNA Position: Q2 2026 in Review

Simplex Trading reduced its Filana Therapeutics (FLNA) stake by 29% in Q2 2026, selling an estimated $57.2K and leaving 99,879 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #5331.

Simplex Trading first reported a position in FLNA in Q1 2015 and has held it in 30 quarters since. The position peaked at $5.05M in Q3 2021. 85 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • Simplex Trading held 99,879 shares of Filana Therapeutics worth $119K as of Q2 2026.
  • Simplex Trading sold 40,116 Filana Therapeutics shares in Q2 2026, an estimated $57.2K.
  • Filana Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #5331 holding.
  • Simplex Trading first reported a position in Filana Therapeutics in Q1 2015 and has held it in 30 quarters since.
  • Simplex Trading's Filana Therapeutics position peaked at $5.05M in Q3 2021.
  • 85 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.